US Edition
Published • loading... • Updated
Impact of Pegylated Interferon Combined with Oral Antiviral Therapy on Liver Fibrosis in Patients with Chronic Hepatitis B: A 48-Week Prospective Cohort Study
Summary by researchsquare.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Impact of Pegylated Interferon Combined with Oral Antiviral Therapy on Liver Fibrosis in Patients with Chronic Hepatitis B: A 48-Week Prospective Cohort Study
Background and Aims:Pegylated interferon (PEG-IFN) combined with oral antiviral agents is currently the most widely used and highly effective treatment regimen for chronic hepatitis B virus (HBV) infection. While effectively suppressing HBV replication, its impact on liver histopatholog...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
